- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: ABBV-221
Total 1797 results
-
National Cancer Institute (NCI)Active, not recruitingAnemia | Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Transformed Non-Hodgkin Lymphoma | Richter Syndrome | Refractory Transformed Non-Hodgkin Lymphoma | Transformed Follicular Lymphoma to Diffuse Large B-Cell LymphomaUnited States
-
University of WashingtonMerck Sharp & Dohme LLCActive, not recruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular LymphomaUnited States
-
Diurnal LimitedCompletedCongenital Adrenal HyperplasiaUnited States
-
Assiut UniversityUnknownArthropathy of Knee
-
The Adelaide and Meath Hospital, incorporating...Unknown
-
The Methodist Hospital Research InstituteTerminated
-
Johnson & Johnson Consumer Inc., McNeil Consumer...Completed
-
ImmunityBio, Inc.UnknownSquamous Cell CarcinomaUnited States
-
ImmunityBio, Inc.Unknown
-
National Cancer Institute (NCI)RecruitingNodular Lymphocyte Predominant B-Cell Lymphoma | Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma | Refractory Nodular Lymphocyte Predominant B-Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnRecurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent T-Cell Non-Hodgkin Lymphoma | Recurrent High Grade B-Cell Lymphoma | Recurrent Aggressive Non-Hodgkin Lymphoma | Recurrent Burkitt Lymphoma | Recurrent Transformed B-Cell Non-Hodgkin LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Recurrent Hodgkin Lymphoma | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Chronic Myelomonocytic Leukemia | Acute Lymphoblastic Leukemia | Lymphoblastic Lymphoma | Myelodysplastic Syndrome | Plasma Cell Myeloma | Aplastic Anemia | Recurrent Non-Hodgkin... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Refractory Mantle Cell Lymphoma | Refractory Small Lymphocytic Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular... and other conditionsUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)RecruitingPembrolizumab Followed by Chemotherapy for the Treatment of Patients With Classical Hodgkin LymphomaClassic Hodgkin LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingHematopoietic and Lymphoid System NeoplasmUnited States
-
NovavaxCoalition for Epidemic Preparedness InnovationsCompletedCOVID-19United States, Australia
-
National Institute of Allergy and Infectious Diseases...CompletedHIV InfectionsUnited States
-
Citius Pharmaceuticals, Inc.Completed
-
LEO PharmaCompletedPsoriasis VulgarisUnited Kingdom, France, Canada
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Adult Hodgkin LymphomaUnited States
-
Baskent UniversityCompletedHip Fracture | Chronic Renal FailureTurkey
-
National Cancer Institute (NCI)RecruitingRecurrent Head and Neck Squamous Cell Carcinoma | Recurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Recurrent Oral Cavity Squamous Cell Carcinoma | Recurrent Oropharyngeal Squamous Cell CarcinomaUnited States
-
National Center for Women and Children's Health...National Center for AIDS/STD Control and Prevention, China CDC; Guangdong Provincial... and other collaboratorsCompleted
-
Assiut UniversityCompletedSystemic Inflammatory Response SyndromeEgypt
-
Alcon ResearchCompletedAcute Otitis Externa
-
Eyegate Pharmaceuticals, Inc.Completed
-
National Cancer Institute (NCI)RecruitingStage IV Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage IIIC Lung Cancer AJCC v8 | Advanced Lung Non-Small Cell CarcinomaUnited States
-
Stanford UniversityCompletedLymphoma | Hodgkin Disease | Lymphoma, Hodgkin Disease | Lymphoma: HodgkinUnited States
-
National Institute of Allergy and Infectious Diseases...Recruiting
-
Tampere University HospitalCompletedPostoperative Pain | Nerve BlockFinland
-
The Hospital for Sick ChildrenCanadian Institutes of Health Research (CIHR); Children's Hospital of Eastern... and other collaboratorsCompleted
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityTerminatedPrimary Myelofibrosis | Anemia | Recurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic... and other conditionsUnited States
-
ImmunityBio, Inc.Withdrawn
-
ImmunityBio, Inc.Withdrawn
-
Mayo ClinicNational Cancer Institute (NCI)Not yet recruitingStage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Metastatic Pancreatic Adenocarcinoma | Locally Advanced Pancreatic Adenocarcinoma | Unresectable Pancreatic AdenocarcinomaUnited States
-
ImmunityBio, Inc.Withdrawn
-
Mayo ClinicRecruitingRecurrent Prostate Cancer | Castration-resistant Prostate Cancer | Stage IVB Prostate Cancer AJCC v8 | Recurrent Castration-Sensitive Prostate CarcinomaUnited States
-
Radboud University Medical CenterActive, not recruitingCoronary Vasospasm | Microvascular Angina | Microvascular Ischemia of MyocardiumNetherlands
-
BayerCompletedDermatitis, PhotoallergicUnited States
-
Joseph TuscanoNational Cancer Institute (NCI); ADC Therapeutics S.A.RecruitingHigh Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Double-Expressor Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 RearrangementsUnited States
-
OHSU Knight Cancer InstituteAbbVie; Oregon Health and Science UniversityRecruitingB Acute Lymphoblastic Leukemia | Recurrent B Acute Lymphoblastic Leukemia | Recurrent Mixed Phenotype Acute Leukemia | B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Mixed Phenotype Acute LeukemiaUnited States
-
M.D. Anderson Cancer CenterRecruitingAnn Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Ann Arbor Stage II Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Ann Arbor Stage III Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Ann Arbor Stage IV Primary Mediastinal (Thymic) Large B-Cell LymphomaUnited States
-
ImmunityBio, Inc.Withdrawn
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedFLT3 Gene Mutation Negative | FLT3 Internal Tandem Duplication Positive | Recurrent Acute Myeloid Leukemia | Recurrent Chronic Myelomonocytic Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic...United States
-
ImmunityBio, Inc.Withdrawn
-
Assistance Publique - Hôpitaux de ParisNot yet recruiting